1. A population‐based study of chronic myeloid leukemia patients treated with imatinib in first line. Issue 1 (18th November 2016) Authors: Castagnetti, Fausto; Di Raimondo, Francesco; De Vivo, Antonio; Spitaleri, Antonio; Gugliotta, Gabriele; Fabbiano, Francesco; Capodanno, Isabella; Mannina, Donato; Salvucci, Marzia; Antolino, Agostino; Marasca, Roberto; Musso, Maurizio; Crugnola, Monica; Impera, Stefana; Trabacchi, Elena; Musolino... Journal: American journal of hematology Issue: Volume 92:Issue 1(2017:Jan.) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes. Issue 3 (3rd March 2016) Authors: Stagno, Fabio; Stella, Stefania; Spitaleri, Antonio; Pennisi, Maria Stella; Di Raimondo, Francesco; Vigneri, Paolo Journal: Expert review of anticancer therapy Issue: Volume 16:Issue 3(2016) Page Start: 273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗